If you are
an adult between ages 18 and 65 living with type 1 diabetes you may be eligible
to take part in the GAZELLE clinical research trial. This trial will look at an
investigational fast-acting insulin to see if it works as effectively as an
existing fast-acting insulin already being used to treat diabetes.
Trial-related medications, procedures, equipment, and supplies will be provided
at no cost; health insurance is not required to participate. Ready to learn
more? Please read on.
The GAZELLE trial aims to understand if an investigational medication is as clinically effective as a currently-approved fast-acting insulin replacement, with the hope of improving patient access with more options for treating type 1 diabetes.
We are looking for people ages 18 to 65 who, among other things:
Have been diagnosed with type 1 diabetes for at least six months Are on a stable once daily dose of basal Lantus or Toujeo injections and multiple daily bolus NovoLog injections for at least 3 months prior to screening
Have not used insulin pump therapy or any anti-diabetic medications other than trial-approved insulins within the last 3 months
Have not used animal insulin (such as from a cow or pig) within the last 2 years
Have not used a regular immunomodulator therapy within the last year
Are able and willing to self-monitor blood glucose, including up to 7 times per day on selected days
Please contact me if you are interested in learning more about this clinical trial.
